Hims & Hers Health Inc. ($HIMS) Stock Forecast: Up 9.2% Today

What is Hims & Hers Health Inc.?

Hims & Hers Health, Inc. (HIMS) operates in the telemedicine and wellness products sector with shares traded on the NYSE and showed a positive market performance today.

Why is Hims & Hers Health Inc. going up?

HIMS stock is up 9.2% on Jun 10, 2026 16:42

• The recent conclusion of the partnership with Novo Nordisk initially impacted trader sentiment negatively, but the current upward movement suggests a shift towards focusing on the company's strong growth in telemedicine.
• Various opinions on the stock range from optimistic projections based on technical analysis and strategic expansions to bearish views due to factors like institutional selling pressure, legal issues, and high valuations, possibly leading to market volatility.
• Market discussions on potential price trends considering support and resistance levels, trendlines, and key fundamentals such as subscriber growth and GLP-1 program advancements could have influenced the prevailing positive sentiment.
• Traders sharing trade strategies, risk assessments, and price objectives exhibit a blend of positivity and caution, illustrating the fluctuating market sentiment towards HIMS.

HIMS Price Chart

HIMS Technical Analysis

HIMS News

Hims & Hers Health, Inc. Class A Trade Ideas — XETR:82W

This page on TradingView aggregates various trade ideas and analyses for Hims & Hers Health, Inc. (XETR:82W, NYSE:HIMS) from different traders. The sentiment ranges from bullish, identifying potential breakouts and uptrends based on technical

https://www.tradingview.com/symbols/XETR-82W/ideas/page-14/

Hims & Hers Health, Inc. Class A Trade Ideas — XETR:82W

This article compiles several trade ideas and analyses for Hims & Hers Health, Inc. (HIMS) from various traders on TradingView. The perspectives range from bearish setups anticipating a pullback due to recent news, particularly the terminated partnership with Novo Nordisk, to bullish outlooks based on technical patterns like cup-and-handle formations and strong fundamental growth in telemedicine. Traders provide specific entry points, targets, and stop-loss levels, reflecting diverse strategies and market sentiments for HIMS.

https://www.tradingview.com/symbols/XETR-82W/ideas/page-7/

Hims & Hers Health, Inc. Class A Trade Ideas — XETR:82W

This article aggregates various trading ideas for Hims & Hers Health, Inc. (XETR:82W, NYSE:HIMS) from different traders on TradingView. The perspectives are mixed, with several traders predicting bullish movements based on technical analysis, market momentum, and strategic expansions, while others remain bearish due to institutional selling pressure, legal concerns, and high valuations. The analyses include specific trade setups, risk factors, and price targets using tools like options trading, Fibonacci levels, and various chart patterns, highlighting the diverse sentiment surrounding the stock.

https://www.tradingview.com/symbols/XETR-82W/ideas/page-6/

Enterprise value to EBITDA ratio of Hims & Hers Health, Inc. Class A – XETR:82W

This article provides financial information for Hims & Hers Health, Inc. Class A, traded on XETR under the symbol 82W. It specifically details the enterprise value to EBITDA ratio for the company. The page also lists various services and resources offered by TradingView, the platform on which this data is presented.

https://www.tradingview.com/symbols/XETR-82W/financials-statistics-and-ratios/enterprise-value-ebitda/

Hims & Hers Health, Inc. Class A Trade Ideas — XETR:82W

This article compiles various trade ideas and technical analyses for Hims & Hers Health, Inc. Class A (XETR:82W, NYSE:HIMS). Traders discuss potential price movements based on support and resistance levels, trendlines, volume profiles, and RSI, with many anticipating upward movement towards targets like $60, $73, or even $100, citing strong fundamentals, subscriber growth, and GLP-1 program momentum. However, some acknowledge short-term bearish possibilities and emphasize risk management around key support levels.

https://www.tradingview.com/symbols/XETR-82W/ideas/page-5/

Trending Today

Plug Power Inc. ($PLUG) Stock Forecast: Down 5.1% Today

Reddit Inc ($RDDT) Stock Forecast: Up 5.0% Today

Sunrun Inc. ($RUN) Stock Forecast: Down 5.1% Today

Aurora Cannabis Inc. ($ACB) Stock Forecast: Down 5.3% Today

Ethereum ($ETH) Crypto Forecast: Up 10.1% Today

Uniswap ($UNI) Crypto Forecast: Up 9.5% Today

DXC Technology Company ($DXC) Stock Forecast: Down 5.0% Today

Perrigo Company plc ($PRGO) Stock Forecast: Down 5.0% Today

StoneCo Ltd. ($STNE) Stock Forecast: Down 5.2% Today

Whirlpool Corporation ($WHR) Stock Forecast: Down 5.0% Today

Hims & Hers Health Inc. Price History

15.04.2026 - HIMS Stock was up 5.8%

• HIMS stock experienced a strong bullish movement today, despite recent mid and long-term weakness highlighted elsewhere.
• The soft start to the year in terms of earnings and the subsequent 9% drop in shares could have initially dampened investor sentiment.
• However, the market seems to have reacted positively to the company's long-term growth prospects, especially with the potential benefits expected from the Novo partnership and international expansion.
• The AI-generated trading strategies and multi-timeframe signal analysis mentioned elsewhere might have contributed to the bullish momentum as well, attracting traders looking for short-term opportunities.

22.03.2026 - HIMS Stock was down 6.1%

• HIMS stock saw a decline today, which may be linked to substantial insider selling by the company's CFO, Okupe Oluyemi, who sold $1.46 million in company stock.
• A comparison between Hims & Hers and Amwell may have added to investor uncertainty, prompting a sell-off of HIMS stock as investors reassess their telehealth investments.
• Insider sales and executives' proposed sales of Class A shares could suggest a lack of confidence in the company's future, impacting investor sentiment and lowering the stock price.
• Despite potential growth opportunities such as upcoming FDA discussions and heightened competition, today's bearish movement in HIMS stock reflects investor caution amid ongoing market shifts and insider selling.

09.05.2026 - HIMS Stock was up 6.3%

• The discontinued partnership with Novo Nordisk may have initially impacted market sentiment negatively. However, traders have now focused on technical patterns like cup-and-handle formations and solid fundamental growth, contributing to the bullish trend.
• There are varied opinions among traders, with some anticipating bullish movements driven by market momentum and strategic expansions. On the contrary, others express bearish views, citing institutional selling pressure and legal uncertainties, resulting in conflicting market sentiment.
• Discussions regarding potential price changes based on support and resistance levels, subscriber growth, and program momentum point towards a predominantly bullish stance, acknowledging potential short-term bearish scenarios.
• Insights derived from price analysis and AI-generated trading strategies indicate a positive sentiment in the near and mid-term, potentially lifting the stock price despite lingering concerns about long-term performance. This reflects a combination of investor optimism and caution.

01.05.2026 - HIMS Stock was up 5.4%

• HIMS stock saw a significant 5.07% bullish movement following notable insider buying by director David B. Wells, reflecting confidence in the company's future.
• An insider's purchase of Class A common stock totaling $1.17 million indicates positive sentiment towards Hims & Hers, potentially signaling undervaluation or future growth opportunities.
• The Q1 results revealed a strategic shift and an increased full-year 2026 revenue guidance, which may have also contributed to the bullish movement, bolstering investor confidence in the company's direction and financial outlook.
• The combined factors of insider buying, positive financial updates, and strategic shifts likely spurred investor optimism and the bullish momentum in HIMS stock.

19.04.2026 - HIMS Stock was down 6.1%

• The company's recent announcement of a $300 million debt offering for convertible senior notes due 2032, aimed at supporting global expansion and technology advancements, caused a 7% decline in the stock price, unsettling investors.
• Concerns have arisen among investors regarding the potential dilution for Class A stockholders resulting from the convertible notes offering, which could impact the company's financial flexibility and shareholder value.
• Market sentiment towards HIMS appears cautious, with an analysis suggesting downside risks in the mid to long term despite short-term optimism.
• The revelation of significant ownership by Susquehanna entities in HIMS may also be influencing the bearish movement, as investors evaluate the consequences of shared voting rights over a substantial portion of the company's outstanding shares.

24.03.2026 - HIMS Stock was up 5.8%

• The bullish movement in HIMS stock today can be attributed to the positive sentiment generated by the Chief Legal Officer and Chief Financial Officer selling shares worth over $280,000 and $588,615 respectively. This could indicate confidence in the company's future performance.
• The uptick in shares following discussions around FDA's removal of certain peptide restrictions might have also contributed to the bullish movement, showing potential growth opportunities for the company in the healthcare sector.
• Comparisons between Hims & Hers and Amwell might have sparked investor interest in HIMS, positioning it favorably against its competitors in the telehealth industry.

05.05.2026 - HIMS Stock was down 6.4%

• The bearish movement in HIMS stock today could be attributed to profit-taking by investors after a period of strong near and mid-term sentiment.
• The weak long-term outlook may have also contributed to the selling pressure on the stock.
• The AI-generated trading strategies provided may have triggered automated sell signals, exacerbating the downward movement in the stock price.
• Investors might be cautious about the support and resistance levels highlighted in the analysis, leading to increased selling pressure and a bearish trend for HIMS today.

27.04.2026 - HIMS Stock was up 5.7%

• The bearish sentiment and bearish short-trade setups may have initially set a negative tone for the stock. However, the market movement suggests that traders may have found value in the company despite the weak sentiment.
• The issuance of zero-coupon convertibles could have sparked investor interest and confidence in the company's future growth prospects, leading to increased buying activity and driving the stock price higher.
• The directors being awarded RSUs could indicate a positive outlook from the company's leadership, potentially boosting investor confidence and contributing to the bullish momentum in the market for HIMS today.

28.03.2026 - HIMS Stock was down 5.6%

• The initiation of a new stock repurchase plan worth up to $250 million by Hims & Hers Health potentially sparked initial investor optimism, resulting in a minor uptick in share prices.
• Subsequently, a series of notable insider selling activities conducted by the CFO and Chief Legal Officer may have triggered investor apprehensions regarding the company's future prospects, leading to a bearish trend in the stock.
• Factors such as the CFO's share sell-off, intensified competition from Amazon in the weight management industry, and uncertainties surrounding FDA regulations concerning peptides likely contributed to a prevailing negative outlook on HIMS stock, overshadowing the positive implications of the buyback initiative.

22.04.2026 - HIMS Stock was up 5.5%

• HIMS recently issued $402.5 million in zero-coupon convertible senior notes due 2032, signaling a strategic move to raise funds for expansion and acquisitions, which likely boosted investor confidence.
• Although the CFO's sale of shares post exercising stock options may have raised initial concerns, the overall positive response to the convertible notes issuance, along with plans for international growth and investment in AI, overshadowed this, driving the market's upward movement.
• Despite a recent earnings disappointment and a decline in share price, the successful pricing of the $350 million convertible notes to support international expansion and AI platform development reassured investors about the company's future prospects, contributing to the positive market trend.

10.05.2026 - HIMS Stock was up 9.2%

• The recent conclusion of the partnership with Novo Nordisk initially impacted trader sentiment negatively, but the current upward movement suggests a shift towards focusing on the company's strong growth in telemedicine.
• Various opinions on the stock range from optimistic projections based on technical analysis and strategic expansions to bearish views due to factors like institutional selling pressure, legal issues, and high valuations, possibly leading to market volatility.
• Market discussions on potential price trends considering support and resistance levels, trendlines, and key fundamentals such as subscriber growth and GLP-1 program advancements could have influenced the prevailing positive sentiment.
• Traders sharing trade strategies, risk assessments, and price objectives exhibit a blend of positivity and caution, illustrating the fluctuating market sentiment towards HIMS.

13.04.2026 - HIMS Stock was down 10.8%

• HIMS stock experienced a bearish movement due to the disappointing first-quarter financial results, with revenue up only 4% and adjusted EBITDA down 51% below guidance.
• The market reacted negatively to the news, causing a 9% drop in HIMS shares.
• Investors may have been concerned about the company's short-term performance, despite the anticipated long-term growth potential through new specialties, regions, and the partnership with Novo.